The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML
出版年份 2011 全文链接
标题
The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML
作者
关键词
-
出版物
BLOOD
Volume 118, Issue 10, Pages 2830-2839
出版商
American Society of Hematology
发表日期
2011-07-07
DOI
10.1182/blood-2010-07-294827
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells
- (2009) W. Fiskus et al. BLOOD
- Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML
- (2009) J. Zhou et al. BLOOD
- EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
- (2009) M.-L. Suva et al. CANCER RESEARCH
- Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression
- (2009) Z L Wu et al. CELL DEATH AND DIFFERENTIATION
- Chromatin maps, histone modifications and leukemia
- (2009) T Neff et al. LEUKEMIA
- DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
- (2009) T. B. Miranda et al. MOLECULAR CANCER THERAPEUTICS
- Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells
- (2009) F. Sun et al. MOLECULAR CANCER THERAPEUTICS
- Epigenetics in cancer: Targeting chromatin modifications
- (2009) L. Ellis et al. MOLECULAR CANCER THERAPEUTICS
- Mechanisms of Polycomb gene silencing: knowns and unknowns
- (2009) Jeffrey A. Simon et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Regulation of PERK Signaling and Leukemic Cell Survival by a Novel Cytosolic Isoform of the UPR Regulator GRP78/BiP
- (2009) Min Ni et al. PLoS One
- DACT3 Is an Epigenetic Regulator of Wnt/β-Catenin Signaling in Colorectal Cancer and Is a Therapeutic Target of Histone Modifications
- (2008) Xia Jiang et al. CANCER CELL
- In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptor
- (2008) Jianbiao Zhou et al. LEUKEMIA RESEARCH
- Roles of the EZH2 histone methyltransferase in cancer epigenetics
- (2008) Jeffrey A. Simon et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities
- (2008) Inki Kim et al. NATURE REVIEWS DRUG DISCOVERY
- Epigenetics in Acute Myeloid Leukemia
- (2008) Christoph Plass et al. SEMINARS IN ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started